Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
Organic Letters
|
December 16, 2005
Stereoselective and efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol
Peter J L M Quaedflieg, Bart R R Kesteleyn, Piet B T P Wigerinck, et al.
Cell Stem Cell
|
September 29, 2015
Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia
Min Ye, Hong Zhang, Henry Yang, et al.
Hormone Molecular Biology and Clinical Investigation
|
January 5, 2016
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study
Céline Bouchard, Fernand Labrie, Leonard Derogatis, et al.
Experimental Hematology
|
February 19, 2022
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation
Enric Redondo Monte, Georg Leubolt, Roland Windisch, et al.
Birth Defects Research
|
November 1, 2024
Stone Babies: A Pictorial Essay With Insights From 25 Museal Lithopaedions
Lucas L Boer, Andreas Wasserscheid, Eduard Winter, et al.
The Journal of Sexual Medicine
|
April 30, 2014
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women
Fernand Labrie, David Archer, Céline Bouchard, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
May 13, 2010
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy
Fernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)
|
May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy
Fernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)
|
May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
Fernand Labrie, David Archer, Céline Bouchard, et al.
Climacteric : the Journal of the International Menopause Society
|
January 20, 2011
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia
F Labrie, D F Archer, C Bouchard, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
Organic Letters
|
December 16, 2005
Stereoselective and efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol
Peter J L M Quaedflieg, Bart R R Kesteleyn, Piet B T P Wigerinck, et al.
Cell Stem Cell
|
September 29, 2015
Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia
Min Ye, Hong Zhang, Henry Yang, et al.
Hormone Molecular Biology and Clinical Investigation
|
January 5, 2016
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study
Céline Bouchard, Fernand Labrie, Leonard Derogatis, et al.
Experimental Hematology
|
February 19, 2022
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation
Enric Redondo Monte, Georg Leubolt, Roland Windisch, et al.
Birth Defects Research
|
November 1, 2024
Stone Babies: A Pictorial Essay With Insights From 25 Museal Lithopaedions
Lucas L Boer, Andreas Wasserscheid, Eduard Winter, et al.
The Journal of Sexual Medicine
|
April 30, 2014
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women
Fernand Labrie, David Archer, Céline Bouchard, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
May 13, 2010
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy
Fernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)
|
May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy
Fernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)
|
May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
Fernand Labrie, David Archer, Céline Bouchard, et al.
Climacteric : the Journal of the International Menopause Society
|
January 20, 2011
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia
F Labrie, D F Archer, C Bouchard, et al.
Page
of 14